ArticleInvestigational new drugs2022

Optimal threshold of alpha-fetoprotein response in patients with unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab.

Nobuharu Tamaki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.